Cannabis Law Report

JUNE 15, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

SEPTEMBER 18, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 52

Compliance Compliance Seed-To-Sale Data 52

Cannabis Law Report

JUNE 16, 2019

Currently available in multiple markets, the CNC card will enable cannabis consumers and dispensaries nationwide to transact electronically using credit in all of Columbia Care’s markets by the end of 2019. First legal, transparent and highly scalable credit card solution available to fast-growing $23B US cannabis industry. Columbia Care Inc.

Programs 40

Programs Dispensary Education Patients 40

NORML

JANUARY 2, 2019

We certainly didn’t expect the opportunity to protest Jeff Sessions alongside Congresswoman Dina Titus and State Senators Aaron Ford & Tick Segerblom at the Apothecary Shoppe Dispensary with every news outlet present, but it happened! December 2018: “Access for All” Patient Voucher Program.

Education 107

Education Media History Advocacy 107

Cannabis Law Report

JUNE 9, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 66

Compliance Compliance Seed-To-Sale Data 66

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. A recent study by Lintzeris et al.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

In addition to convincing marijuana dispensaries to widely carry CBD, they wanted to educate the public about its promising benefits. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

DECEMBER 8, 2021

By sufficiently moving the needle on public opinion, NORML aims to legalize the responsible use of marijuana by adults, and subsequently ensure access to products that are safe, convenient, and affordable. To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today!

Access 81

Access Policy Patients Cannabis 81